Treatment Strategies for Eczematous Disorders

Foundations First - Eczema Care Basics

• Emollients: Cornerstone of therapy.
  • Apply liberally & frequently (e.g., 2-3 times/day or more, esp. post-bath within 3 mins).
  • Restores skin barrier; various types (lotions, creams, ointments).
• Trigger Avoidance: Identify & eliminate.
  • Irritants: Soaps, detergents, fragrances, harsh chemicals.
  • Allergens: Dust mites, pollens, molds, certain foods (less common in adults).
• Bathing Practices: Gentle approach.
  • Lukewarm water, short duration (5-10 mins).
  • Use mild, non-soap, fragrance-free cleansers (syndets).
  • Pat dry gently; avoid vigorous rubbing.
• Clothing: Soft, breathable fabrics (e.g., cotton); avoid wool/synthetics.
• Scratch Prevention: Minimize skin trauma.
  • Keep fingernails short.
  • Consider cotton gloves at night for children.

⭐ Regular and liberal use of emollients can significantly reduce disease severity, flare frequency, and the amount of topical corticosteroids needed.

Topical Titans - Steroids & Friends

• Topical Corticosteroids (TCS): First-line; anti-inflammatory, vasoconstrictive.

  • Potency selection is key (↓ for face/flexures, ↑ for thick lesions). Examples:
    • Mild: Hydrocortisone 1%
    • Moderate: Clobetasone butyrate 0.05%
    • Potent: Betamethasone valerate 0.1%
    • Very Potent: Clobetasol propionate 0.05%
  • Application: Thin layer. 📌 Fingertip Unit (FTU) = 0.5g (covers 2 adult palms).
  • Side Effects: Atrophy, striae, tachyphylaxis, HPA axis suppression (rare with proper use). ⭐ > Tachyphylaxis, a decreased response to a drug, is a common concern with prolonged, uninterrupted use of high-potency topical corticosteroids.

• Topical Calcineurin Inhibitors (TCIs): Steroid-sparing; inhibit T-cell activation; no skin atrophy.

  • Examples: Tacrolimus (0.03%, 0.1%), Pimecrolimus (1%).
  • Use: Sensitive areas (face, eyelids, flexures), long-term maintenance.
  • Side Effects: Transient burning/stinging. ⚠️ Rare lymphoma risk (FDA warning).

• Other Agents:

  • Crisaborole (2% ointment): PDE4 inhibitor for mild-moderate atopic dermatitis.

Systemic Solutions - Heavy Hitters

For severe, refractory, or widespread eczema when topicals fail.

• Systemic Corticosteroids (SCS)

  • Use: Acute, severe flares.
  • Drug: Prednisolone 0.5-1 mg/kg/day (short course, taper).
  • ⚠️ Risks: Prolonged use leads to HPA axis suppression, Cushing's.

• Conventional Immunosuppressants (Steroid-sparing)

  • Use: Chronic severe eczema, reduce steroid need.
  • Cyclosporine A (CsA): 2.5-5 mg/kg/day. Rapid. Monitor BP, renal function.

    ⭐ Cyclosporine: often first-choice for rapid control in severe atopic dermatitis due to quick onset.

  • Azathioprine (AZA): 1-3 mg/kg/day. Check TPMT. Myelosuppression.
  • Methotrexate (MTX): 10-25 mg/week. Hepatotoxicity. Folic acid.
  • Mycophenolate Mofetil (MMF): 1-2 g/day. GI upset.

• Biologics

  • Dupilumab (IL-4/IL-13 inhibitor): Mod-severe Atopic Dermatitis.
  • Dose: 600 mg SC load, then 300 mg SC q2w.
  • SE: Conjunctivitis, injection site reactions.

• Oral JAK Inhibitors

  • Upadacitinib, Abrocitinib.
  • Use: Mod-severe Atopic Dermatitis.
  • ⚠️ Risks: Infections, VTE (Black Box).

Light & More - Adjunct Arsenal

• Phototherapy: Chronic, widespread, refractory eczema.
  • NB-UVB: Preferred (311-313 nm); good efficacy, safety.
  • PUVA: Potent; severe cases. Higher photocarcinogenesis risk.
• Wet Wraps: Acute severe flares (esp. AD).
  • Rapidly ↓itch/inflammation. Over emollients/dilute steroids.
• Antihistamines: For pruritus.
  • Sedating (e.g., Hydroxyzine): Nocturnal itch.
  • Non-sedating: Limited role in eczema itch.
• Dilute Bleach Baths: (0.005% $NaOCl$)
  • ↓S. aureus, anti-inflammatory. 2-3x/week.
• Stress Management: Essential; stress exacerbates eczema.

⭐ NB-UVB: first-line phototherapy for AD; better risk-benefit than PUVA.

High‑Yield Points - ⚡ Biggest Takeaways

• Topical corticosteroids (TCS) are the mainstay of treatment; potency selection is crucial.
• Emollients are foundational; use liberally and frequently to restore skin barrier.
• Topical calcineurin inhibitors (TCIs) like tacrolimus, pimecrolimus are steroid-sparing, good for sensitive areas.
• Antihistamines for pruritus control, though sedative effects may be primary benefit.
• Systemic corticosteroids for severe, acute flares; short courses preferred.
• Phototherapy (UVB, PUVA) for chronic, widespread eczema refractory to topical agents.
• Dupilumab targets IL-4 & IL-13 for moderate-to-severe atopic dermatitis_._